Company Overview

INHIBRX BIOSCIENCES, INC.

INBX
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
1M
2025 FY
Net Income
-140M
2025 FY
Shares Outstanding
15M
2025 FY
EPS
-9.04USD
2025 FY
Company Information
SIC Code
2836
CIK Code
2007919
Exchange
Nasdaq
Location
US